SARS-CoV-2 Vaccine-Related Adverse Events in Zimbabwe: The Need to Strengthen Pharmacovigilance in resource-limited settings

Authors: Grant Murewanhema, Tafadzwa Dzinamarira, Roda Madziva, Helena Herrera, Godfrey Musuka

We discuss various strategies for strengthening pharmacovigilance in Zimbabwe, a limited resource country, using tailored, robust reporting or other pharmacoepidemiological methods that systematically collect and analyze adverse events associated with the use of COVID-19 vaccines, identify signals or emerging problems, and communicate how to minimize or prevent harm.

SARS-CoV-2 Vaccine-Related Adverse Events in Zimbabwe: The Need to Strengthen Pharmacovigilance in resource-limited settings

Available Resources

SARS-CoV-2 Vaccine-Related Adverse Events in Zimbabwe: The Need to Strengthen Pharmacovigilance in resource-limited settings

Enter keyword:

Select a category:

Select a tag:

Select a location:

Related Items

Differentiated Care for Adults at High Risk of HIV Disease Progression: A Call to Action

HIV-Related Stigma, Social Support, and Psychological Distress Among Individuals Initiating ART in Ethiopia.

Youth-friendly services and differentiated models of care are needed to improve outcomes for young people living with HIV.

Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda